ConsiGma® 4.0 from GEA makes Continuous Manufacturing Technology available to all
2020-06-25
In a significant step forward to bring continuous processing technology to a broader pharmaceutical customer segment, GEA has repositioned it’s ConsiGma® portfolio to ensure that new drugs can be brought to market as quickly and cost-effectively as possible. As the world emerges from the global Sars-CoV-2 coronavirus pandemic, the pharmaceutical industry — perhaps one of the most “essential” manufacturing sectors — is witnessing a period of unprecedented change.
